MARATTO

article · Tissue and Cell

Alogliptin mitigates doxorubicin-induced cardiotoxicity in rats: Implications of SIRT3/NRF2 pathway and miRNA-133a

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Chemotherapy-induced cardiotoxicity and mitigation
  • Sirtuins and Resveratrol in Medicine
  • Lung Cancer Research Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.tice.2026.103910

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.